Merck & Co Inc (MRK)
131.73
+3.07
(+2.39%)
USD |
NYSE |
May 15, 16:00
132.09
+0.36
(+0.27%)
After-Hours: 20:00
Merck Price to Book Value: 8.265 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 8.073 |
| May 13, 2024 | 8.113 |
| May 10, 2024 | 8.161 |
| May 09, 2024 | 8.172 |
| May 08, 2024 | 8.129 |
| May 07, 2024 | 8.181 |
| May 06, 2024 | 8.005 |
| May 03, 2024 | 8.001 |
| May 02, 2024 | 8.048 |
| May 01, 2024 | 8.082 |
| April 30, 2024 | 8.108 |
| April 29, 2024 | 8.166 |
| April 26, 2024 | 8.233 |
| April 25, 2024 | 8.203 |
| April 24, 2024 | 7.970 |
| April 23, 2024 | 7.962 |
| April 22, 2024 | 7.966 |
| April 19, 2024 | 7.893 |
| April 18, 2024 | 7.859 |
| April 17, 2024 | 7.868 |
| April 16, 2024 | 7.848 |
| April 15, 2024 | 7.919 |
| April 12, 2024 | 7.891 |
| April 11, 2024 | 7.916 |
| April 10, 2024 | 7.954 |
| Date | Value |
|---|---|
| April 09, 2024 | 7.952 |
| April 08, 2024 | 7.942 |
| April 05, 2024 | 8.032 |
| April 04, 2024 | 8.011 |
| April 03, 2024 | 8.152 |
| April 02, 2024 | 8.180 |
| April 01, 2024 | 8.220 |
| March 31, 2024 | |
| March 28, 2024 | 8.895 |
| March 27, 2024 | 8.881 |
| March 26, 2024 | 8.461 |
| March 25, 2024 | 8.447 |
| March 22, 2024 | 8.349 |
| March 21, 2024 | 8.333 |
| March 20, 2024 | 8.349 |
| March 19, 2024 | 8.237 |
| March 18, 2024 | 8.186 |
| March 15, 2024 | 8.192 |
| March 14, 2024 | 8.124 |
| March 13, 2024 | 8.235 |
| March 12, 2024 | 8.268 |
| March 11, 2024 | 8.276 |
| March 08, 2024 | 8.325 |
| March 07, 2024 | 8.358 |
| March 06, 2024 | 8.342 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.866
Minimum
Feb 24 2022
8.895
Maximum
Mar 28 2024
6.648
Average
6.727
Median
Jul 24 2020
Price to Book Value Benchmarks
| Amgen Inc | 34.08 |
| Johnson & Johnson | 5.248 |
| Eli Lilly and Co | 58.42 |
| Pfizer Inc | 1.769 |
| Moderna Inc | 3.859 |
Price to Book Value Related Metrics
| PE Ratio | 146.36 |
| PS Ratio | 5.454 |
| Price to Free Cash Flow | 30.34 |
| Price | 131.73 |
| Earnings Yield | 0.68% |
| Market Cap | 333.62B |
| Operating PE Ratio | 68.25 |
| Normalized PE Ratio | 110.01 |